BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, January 19, 2026
Home » Authors » Larry Haimovitch

Articles by Larry Haimovitch

Prostate cancer therapies in the spotlight at AUA meeting

April 30, 2009
By Larry Haimovitch
CHICAGO — The annual meeting of the American Urological Association (AUA; Linthicum, Maryland) the largest worldwide meeting for this specialty, is taking place here. Although a broad variety of topics are traditionally covered at this meeting, prostate cancer remains a crucial focus at every AUA meeting. And well it should, as it is the most common cancer in men with about one in six American men predicted to get prostate cancer during his lifetime. (Diagnostics & Imaging Week)
Read More

Prostate cancer therapies in the spotlight at AUA meeting

April 29, 2009
By Larry Haimovitch
CHICAGO — The annual meeting of the American Urological Association (AUA; Linthicum, Maryland) the largest worldwide meeting for this specialty, is taking place here. Although a broad variety of topics are traditionally covered at this meeting, prostate cancer remains a crucial focus at every AUA meeting. And well it should, as it is the most common cancer in men with about one in six American men predicted to get prostate cancer during his lifetime. (Medical Device Daily)
Read More

Study shows costs improve for DES vs. surgery for some patients

April 1, 2009
By Larry Haimovitch
ORLANDO — With a massive number of clinical trial data being reported here the past few days, winnowing out the most important ones became a major challenge. However, one trial that stood out from the crowd because of its focus on quality of life (QOL) and healthcare cost outcomes was the Synergy between PCI with Taxus and Cardiac Surgery (SYNTAX) trial. (Medical Device Daily)
Read More

Watchman shown to be better than warfarin for non-valvular AF

March 31, 2009
By Larry Haimovitch
ORLANDO — The 58th annual scientific session of the American College of Cardiology (ACC; Bethesda, Maryland) kicked off here early on Saturday morning with a session devoted to "Late Breaking Clinical Trials." (Medical Device Daily)
Read More

AFib seen as a hot sector for new technology developments

March 11, 2009
By Larry Haimovitch

Macular degeneration remains a key topic for retinal specialists

March 1, 2009
By Larry Haimovitch

Despite missing its endpoint, NEST-2 trial shows promise

Feb. 24, 2009
By Larry Haimovitch

Macular degeneration a key topic for retinal specialists

Jan. 28, 2009
By Larry Haimovitch
WAILEA MAUI, Hawaii – The annual Hawaiian Eye Meeting was held here last week at the Grand Wailea Resort as specialists from three key ophthalmic specialties – cataract, refractive and retinal surgery – gathered to hear the latest clinical information and to enjoy the sunny and warm weather. (Medical Device Daily)
Read More

Big proposed deal sharpens focus on ophthalmology space

Jan. 21, 2009
By Larry Haimovitch

Economy roils sector, but big players cite some positive signs

Jan. 1, 2009
By Larry Haimovitch
Previous 1 2 … 5 6 7 8 9 10 11 12 13 … 18 19 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 16, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 16, 2026.
  • Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal

    BioWorld
    With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
  • Illustration of human body surrounded by DNA, cell and drug icons

    Cell/gene therapy sector now sustainable; China competition mounting

    BioWorld
    There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
  • Businesswoman pressing dollar sign on touchscreen

    JPM 2026: Year kicks off with biopharma Q4 revenue and guidance

    BioWorld
    It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing